Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 473 - Heterocyclic compounds containing purine ring systems
Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
07/2010
07/21/2010CN101784557A Azido purine nucleosides for treatment of viral infections
07/21/2010CN101784548A Purine derivatives and their use as modulators of Toll-like receptor 7
07/21/2010CN101781301A Method for preparing entecavir
07/21/2010CN101781300A Entecavir salt compound, preparation method and medicine application thereof
07/20/2010US7759355 administering a xanthine derivative such as (E)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methylxanthine
07/20/2010US7759342 such as 8-(2-Fluorophenylamino)-2-(4-methoxyphenylamino)-9-(trans-4-(methylamino)cyclohexyl)-9H-purine, used for for inhibiting neutrophil accumulation in bronchoalveolar lavage fluid
07/20/2010CA2486399C Calcium receptor modulating agents
07/15/2010WO2010080306A1 Purine compounds
07/15/2010WO2010036904A3 Preparation of valganciclovir and its salts
07/15/2010US20100179309 MODIFIED iRNA AGENTS
07/15/2010US20100179128 Xanthine derivatives as selective hm74a agonists
07/15/2010CA2746740A1 Purine compounds
07/14/2010EP2205601A1 Purine derivatives as adenosine al receptor ligands
07/14/2010EP2125814B1 Process for the preparation of abacavir
07/14/2010EP1853602B1 Chemical compounds
07/13/2010US7754728 Adenine compound and use thereof
07/08/2010US20100173917 Urea derivatives as abl modulators
07/08/2010US20100173916 Xanthine Derivatives, the Preparation Thereof and Their Use as Pharmaceutical Compositions
07/08/2010US20100173863 2-Fluoronucleosides
07/08/2010US20100172993 Particles for delivery of active ingredients, process of making and compositions thereof
07/07/2010EP2203451A2 Substituted 6-(alkylbenzylamino)purine derivatives for use as cytokinin receptor antagonists and preparations containing these derivatives
07/06/2010US7750160 inhibit p38, MAP kinase interacting serine/threonine kinase 2 (MKNK2 kinase) and serine-threonine kinases (STKs); treating proliferative diseases including cancer, leukemias; e.g. N-(isoxazolyl)urea compounds and thiourea compounds
07/06/2010US7750153 crystalline alkali metal or alkaline earth metal salt of 2',3'-dideoxy-2',3'-didehydroinosine; catalytic hydrogenation and then neutralized with hydrochloric acid
07/01/2010WO2010074534A2 Novel intermediate and process for preparing entecavir using same
07/01/2010WO2010072776A1 Salt forms of organic compound
07/01/2010US20100168425 Antihistaminic and antiallergic agent and a method for the production thereof
07/01/2010US20100168139 Inhibitors of human phosphatidylinositol 3-kinase delta
07/01/2010US20100168122 Xanthine derivatives as selective hm74a agonists
07/01/2010US20100168114 Invertebrate acetylcholinesterase inhibitors
07/01/2010CA2747777A1 A method for preparing entecavir and intermediates thereof
07/01/2010CA2745037A1 Salt forms of organic compound
06/2010
06/30/2010CN101759698A Method for preparing entecavir
06/29/2010US7745608 Conjugated lipophilic group with a modified nucleotide is used to target disease gene, cells, tissue, for drug delivery to entrance into tumor cells; ribose sugar of nucleotide is replaced with a cyclic carrier which has at least one attached phosphate or phosphorothioate group; antitumor biodrugs
06/29/2010US7745452 Quinazolinone T-type calcium channel antagonists
06/29/2010US7745436 Disalt inhibitors of IL-12 production
06/29/2010CA2345985C Substituted 1,3-diaryl-2-pyrid-2-yl-3-(pyrid-2-ylamino)propanol derivatives,processes for their preparation, pharmaceuticals comprising these compounds and their use
06/24/2010WO2010032974A3 Improved production method for adefovir dipivoxil
06/24/2010WO2010032958A3 Stabilized solid dispersion of adefovir dipivoxil and preparation method thereof
06/24/2010US20100160354 Novel compounds
06/24/2010US20100160352 Adenine derivatives
06/24/2010US20100160288 Purine Compounds
06/23/2010EP2197872A1 Phenylisoquinoline and phenylquinazoline derivatives for the treatment of bone diseases
06/23/2010CN101048410B HIV inhibiting bicyclic pyrimidine derivatives
06/22/2010US7741341 Benzimidazole-derivatives as factor Xa inhibitors
06/22/2010US7741331 Use treating atherosclerosis, angiogenesis, type II diabetes, diabetic retinopathy, cancer, and asthma; for example, 3-ethyl-1-propyl-8-(1-[(3-trifluoromethylphenyl)methyl]pyrazol-4-yl)-1,3,7-trihydropurine-2,6-dione
06/17/2010WO2010068581A1 Novel compounds
06/17/2010WO2010068171A1 A process for the preparation of 3- [ (2r) tetrahydrofuran-2- ylmethyl] -2-thioxo-l, 2, 3, 7-tetrahydro-6h-purin-6-one
06/17/2010WO2010066970A1 Novel flavour enhancer compounds
06/17/2010US20100152211 Inhibitors of human phosphatidylinositol 3-kinase delta
06/17/2010US20100152210 Purinyl derivatives and their use as potassium channel modulators
06/17/2010CA2746316A1 Novel compounds
06/16/2010EP2195459A2 Nucleobase characterisation
06/16/2010EP2195319A1 Valomaciclovir polymorphs
06/16/2010EP1349857B1 Purine derivatives as purinergic receptor antagonists
06/16/2010CN1938307B 9-substituted 8-oxoadenine compound
06/16/2010CN101735218A Piperidine carbamic acid ester derivative and application thereof
06/16/2010CN101284811B Synthetic method for chiral carbocyclic ring intermediate of abacavir
06/15/2010US7737127 2-propynyl adenosine analogs having A2A agonist activity and compositions thereof
06/10/2010US20100144738 Inhibitors of c-met and uses thereof
06/10/2010US20100144705 Egfr kinase knockdown via electrophilically enhanced inhibitors
06/10/2010US20100144703 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
06/10/2010US20100144663 2, 6-Dinitrogen-Containing Substituted Purine Derivatives, The Preparation And Uses Thereof
06/09/2010CN1894250B Substituted 8-heteroaryl xanthines
06/09/2010CN1882589B Novel heterocyclic compounds as HSP90-inhibitors
06/09/2010CN101730697A Imidazolopyrimidine analogs and their use as pi3 kinase and mtor inhibitors
06/09/2010CN101723945A Method for preparing antiviral medicinal entecavir intermediate
06/09/2010CN101289448B Method for preparing 1,3,7,9-tetramethyl uric acid
06/08/2010US7732484 Use of selective adenosine A1 receptor allosteric enhancers to manipulate angiogenesis
06/08/2010US7732455 Adenosine A2B receptor antagonists; asthma, allergies, allergic diseases or an autoimmune disease, diarrheal diseases, insulin resistance, diabetes, cancer, ischemia, reperfusion injuries, retinopathy; e.g. 1,3-Dipropyl-8-(6-chloro-3-pyridyl)xanthine
06/03/2010WO2010061931A1 Cyclobutyl purine derivative, angiogenesis promoting agent, lumenization promoting agent, neurocyte growth promoting agent, and drug
06/03/2010WO2010061180A1 Quinoline derivatives as p13 kinase inhibitors
06/03/2010US20100137592 Process for preparing purine derivative
06/03/2010US20100137566 Compounds and Methods Used to Treat Infectious Diseases
06/03/2010CA2744857A1 Cyclobutyl purine derivative, angiogenesis promoting agent, lumen formation promoting agent, neurocyte growth promoting agent, and drug
06/02/2010EP2190843A1 Benzimidazole nf- kappab inhibitors
06/02/2010CN101220032B Novel method for producing theobromine with 3_methylxanthine disodium salt methylating
06/01/2010US7727997 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
06/01/2010US7727995 Antiherpes drug combinations
06/01/2010US7727994 administering adenosine receptor antagonist; side effect reduction; Parkinson's disease
06/01/2010US7727993 administering adenosine receptor antagonist with dopamine antagonist;; Parkinson's disease; side effect reduction; low dosage of dopamine
05/2010
05/27/2010WO2010059418A1 Substituted triazine and purine compounds, methods of inhibiting cruzain and rhodesain and methods of treating chagas disease and african trypanosomiasis
05/27/2010WO2010059401A2 Compounds that expand hematopoietic stem cells
05/27/2010US20100130516 Purinyl derivatives and their use as potassium channel modulators
05/27/2010US20100130513 Benzimidazoles and analogs thereof as antivirals
05/27/2010US20100130506 Organic Compounds
05/27/2010US20100130498 Agonists of bitter taste receptors and uses thereof
05/27/2010US20100130491 9-substituted-8-oxo-adenine compounds as toll-like receptor (tlr7 ) modulators
05/27/2010US20100130476 Compounds that induce pancreatic beta-cell expansion
05/27/2010CA2740589A1 Compounds that expand hematopoietic stem cells
05/26/2010EP2188255A1 Heterocyclic amides useful for the treatment of cancer and psoriasis
05/26/2010EP2187889A2 Use of purine derivatives for the manufacture of a medicament
05/26/2010EP1562946B1 Novel xanthine derivatives, the production and the use thereof in the form of drugs
05/26/2010CN101715453A heterocyclic compounds and their uses
05/25/2010US7723509 Conjugated lipophilic group with a modified nucleotide is used to target disease gene, cells, tissue, for drug delivery to target tumor cells; ribose sugar of nucleotide is replaced with a cyclic carrier which has at least one attached phosphate or phosphorothioate group; biodrugs
05/25/2010US7723357 Thalidomide and thalidomide derivatives for treating spinal disorders mediated by nucleus pulposus
05/25/2010US7723340 mitogen-activated protein kinase 8 inhibitors, used for treating or preventing cancer, cardiovascular diseases, renal diseases, autoimmune disorders, inflammatory disorders, vision defects, ischemia-reperfusion injuries, pain and hypertension
05/20/2010WO2010057126A1 Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors
05/20/2010WO2010056907A2 Compounds that induce pancreatic beta-cell expansion
05/20/2010WO2010056563A1 Akt and p70 s6 kinase inhibitors
05/20/2010US20100125062 Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors
1 ... 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 ... 120